Kodu・Aktsiate loetelu・ANI Pharmaceuticals Inc

ANI Pharmaceuticals Inc

Avatud

SektorTervishoid

79.09 -0.63

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

77.72

Max

80.16

Põhinäitajad
By Trading Economics
Sissetulek	-61K 27M
Müük	-9.6M 237M
P/E Sektori keskmine	20.044 64.641
Aktsiakasum	1.68
Kasumimarginaal	11.551
Töötajad	970
EBITDA	-20M 57M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+36.15% upside

Dividendid
By Acuity
Järgmine tulemuste avaldamine	7. aug 2026

Turustatistika
By TradingEconomics
Turukapital	-91M 1.8B
Eelmine avamishind	79.72
Eelmine sulgemishind	79.09

Uudiste sentiment

By Acuity

14%

86%

19 / 340 Pingereas Healthcare

ANI Pharmaceuticals Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

3. aug 2026, 19:46 UTC

ANI Pharmaceuticals is trading higher since Friday's close, despite a flat overall session. The stock remains near the lower end of its one-month range.

31. juuli 2026, 20:06 UTC

ANI Pharmaceuticals Inc. shares are declining amid unusual volatility, with trading lower since Thursday as inflation concerns rise alongside US Treasury yields and crude oil prices.

30. juuli 2026, 20:09 UTC

ANI Pharmaceuticals Inc. shares are lower during Thursday's session, following a notable dip in late morning trading amid mixed economic signals impacting broader market conditions.

29. juuli 2026, 19:19 UTC

ANI Pharmaceuticals shares are higher, rebounding after an earlier pullback. Market sentiment is influenced by expectations for the Federal Reserve's monetary policy announcement today.

28. juuli 2026, 20:02 UTC

ANI Pharmaceuticals is advancing today, continuing an upward trend since Monday, despite declines in broader market sectors, particularly technology stocks in Asia.

24. juuli 2026, 20:06 UTC

News

ANI Pharmaceuticals shares are lower today amid mixed market sentiment for healthcare stocks. The company plans to discuss its Q2 2026 financial results on August 7, 2026.

22. juuli 2026, 20:01 UTC

News

Shares of ANI Pharmaceuticals are lower amid concerns over potential tariffs on imported generic drugs. The stock is near the lower end of its one-month range.

21. juuli 2026, 20:12 UTC

ANI Pharmaceuticals Inc. shares are lower in after-market trading, positioned below the 20-day moving average and near the lower end of their one-month range.

20. juuli 2026, 19:46 UTC

News

Social Media

ANI Pharmaceuticals shares are lower despite positive results from the Phase 4 SYNCHRONICITY trial, which may support expanded use of ILUVIEN.

Võrdlus sarnastega

Hinnamuutus

ANI Pharmaceuticals Inc Prognoos

Hinnasiht

By TipRanks

36.15% tõus

12 kuu keskmine prognoos

Keskmine 109 USD 36.15%

Kõrge 124 USD

Madal 91 USD

Põhineb 6 Wall Streeti analüütiku instrumendi ANI Pharmaceuticals Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

6 ratings

Osta

Hoia

Müü

Põhineb 6 analüütiku instrumendi ANI Pharmaceuticals Inc aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

19 / 340 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest ANI Pharmaceuticals Inc

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.